Captix Biomedical Pty Ltd
CaptixBioTM is investing in collaborative projects to support the innovative application of cell and tissue technologies to improve disease management and ultimately deliver a widely accessible cure for Type 1 diabetes that does not require lifelong immuno-suppression therapy.
Ms Helen Wray
Managing DirectorCook Medical
Founded in Indiana in 1963, Cook Medical pioneered many of the medical devices now commonly used to perform minimally invasive medical procedures. Since its inception, Cook has operated as a family-held private corporation, dedicated to a patient first business philosophy. Today, the Cook Group has grown to 60 companies internationally, including Cook Medical Australia.
Cook Medical Australia has been operating in Australia since 1979, and was one of the first businesses to operate from
Brisbane Technology Park. Its state-of-the-art manufacturing and R&D facility now employs more than 600 people. Cook
Medical Australia manufactures endovascular stent grafts for the treatment of aortic aneurysms, and is one of the few sites in the world that custom-makes these products to fit individual patient anatomies. The company also develops and manufactures products used in the IVF process.
Cook Medical’s Australian operations also double as the headquarters for the Asia-Pacific region.